Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR4 | O00206 | 2/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5951231 | 1.00 | TLR4 (0.41) | TLR4CYP2C9CYP1A2LMNAALDH1A1 | |
| SCHEMBL2234127 | 0.93 | CYP2C9 (0.39) | TLR4CYP2C9CYP1A2LMNAALDH1A1 | |
| SCHEMBL21220106 | 0.90 | CYP2C9 (0.38) | TLR4CYP2C9CYP1A2LMNAALDH1A1 | |
| Acetic Acid SCHEMBL8734367 | 0.90 | TLR4 (0.46) | TLR4CYP2C9CYP1A2LMNAALDH1A1 | |
| SCHEMBL5836340 | 0.87 | TLR4 (0.42) | TLR4CYP2C9CYP1A2LMNAALDH1A1 | |
| SCHEMBL5836344 | 0.87 | TLR4 (0.42) | TLR4CYP2C9CYP1A2LMNAALDH1A1 | |
| SCHEMBL6697654 | 0.87 | TLR4 (0.42) | TLR4CYP2C9CYP1A2LMNAALDH1A1 | |
| SCHEMBL5951084 | 0.86 | CYP1A2 (0.52) | TLR4CYP2C9CYP1A2LMNAMAPT | |
| SCHEMBL5951237 | 0.86 | CYP1A2 (0.52) | TLR4CYP2C9CYP1A2LMNAMAPT | |
| SCHEMBL5951082 | 0.86 | CYP1A2 (0.52) | TLR4CYP2C9CYP1A2LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114349586-B | Preparation method of trans-alkyl bicyclohexane liquid crystal monomer | 阜阳欣奕华材料科技有限公司 | 2023-10-20 | — | — | CN | disclosed |
| CN-114349586-A | Preparation method of trans-alkyl bicyclohexyl liquid crystal monomer | 阜阳欣奕华材料科技有限公司 | 2022-04-15 | — | — | CN | disclosed |
| EP-3228682-A2 | NEMATIC LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME | DIC Corporation (JP) | 2017-10-11 | — | — | EP | disclosed |
| WO-2017020998-A1 | LIQUID CRYSTAL MEDIUM | MERCK PATENT GMBH (DE) | 2017-02-09 | — | — | WO | disclosed |
| EP-2351727-B1 | LIQUID CRYSTAL COMPOUND AND PROCESS FOR PRODUCTION THEREOF, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL ELECTROOPTICAL ELEMENT | AGC SEIMI CHEMICAL CO LTD (JP) | 2014-07-23 | — | — | EP | disclosed |
| US-8283001-B2 | Liquid crystal compound and process for production thereof, liquid crystal composition, and liquid crystal electrooptical element | AGC SEIMI CHEMICAL CO., LTD. (JP) | 2012-10-09 | — | — | US | disclosed |
| US-8283001-B2 | Liquid crystal compound and process for production thereof, liquid crystal composition, and liquid crystal electrooptical element | AGC SEIMI CHEMICAL CO., LTD. (JP) | 2012-10-09 | — | — | US | disclosed |
| US-8273420-B2 | Liquid crystal compound and process for production thereof, liquid crystal composition, and liquid crystal electrooptical element | AGC SEIMI CHEMICAL CO., LTD. (JP) | 2012-09-25 | — | — | US | disclosed |
| US-8273420-B2 | Liquid crystal compound and process for production thereof, liquid crystal composition, and liquid crystal electrooptical element | AGC SEIMI CHEMICAL CO., LTD. (JP) | 2012-09-25 | — | — | US | disclosed |
| US-20120105792-A1 | LIQUID CRYSTAL COMPOUND AND PROCESS FOR PRODUCTION THEREOF, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL ELECTROOPTICAL ELEMENT | AGC SEIMI CHEMICAL CO., LTD. (JP) | 2012-05-03 | — | — | US | disclosed |
| US-20120105792-A1 | LIQUID CRYSTAL COMPOUND AND PROCESS FOR PRODUCTION THEREOF, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL ELECTROOPTICAL ELEMENT | AGC SEIMI CHEMICAL CO., LTD. (JP) | 2012-05-03 | — | — | US | disclosed |
| US-20120050661-A1 | LIQUID CRYSTAL COMPOUND AND PROCESS FOR PRODUCTION THEREOF, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL ELECTROOPTICAL ELEMENT | AGC SEIMI CHEMICAL CO., LTD. (JP) | 2012-03-01 | — | — | US | disclosed |
| US-20120050661-A1 | LIQUID CRYSTAL COMPOUND AND PROCESS FOR PRODUCTION THEREOF, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL ELECTROOPTICAL ELEMENT | AGC SEIMI CHEMICAL CO., LTD. (JP) | 2012-03-01 | — | — | US | disclosed |
| EP-2351727-A1 | LIQUID CRYSTAL COMPOUND AND PROCESS FOR PRODUCTION THEREOF, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL ELECTROOPTICAL ELEMENT | AGC Seimi Chemical Co., Ltd. (JP) | 2011-08-03 | — | — | EP | disclosed |
| US-7074464-B2 | Perfluoropropenyl-containing compound, liquid crystal composition and liquid crystal display element | CHISSO PETROCHEMICAL CORPORATION (JP) | 2006-07-11 | — | — | US | disclosed |
| EP-1477546-B1 | Perfluoropropenyl-containing compound, liquid crystal composition and liquid crystal display element | CHISSO PETROCHEMICAL CORP (JP) | 2006-05-24 | — | — | EP | disclosed |
| US-20050006624-A1 | Perfluoropropenyl-containing compound, liquid crystal composition and liquid crystal display element | JNC PETROCHEMICAL CORPORATION (JP) | 2005-01-13 | — | — | US | disclosed |
| EP-1477546-A1 | Perfluoropropenyl-containing compound, liquid crystal composition and liquid crystal display element | Chisso Petrochemical Corporation (JP) | 2004-11-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120050661-A1 | LIQUID CRYSTAL COMPOUND AND PROCESS FOR PRODUCTION THEREOF, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL ELECTROOPTICAL ELEMENT | CNOT9, AUP1, SFPQ | TLR4 3478/4885CYP2C9 1025/4885CYP1A2 2657/4885 |
| US-20120105792-A1 | LIQUID CRYSTAL COMPOUND AND PROCESS FOR PRODUCTION THEREOF, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL ELECTROOPTICAL ELEMENT | HCN2, CPNE4, HCN1 | TLR4 4491/4885CYP2C9 2964/4885CYP1A2 1772/4885 |
| US-20050006624-A1 | Perfluoropropenyl-containing compound, liquid crystal composition and liquid crystal display element | SCO2, FFAR2, RCC2 | TLR4 4088/4885CYP2C9 1744/4885CYP1A2 605/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.